Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling the Mechanisms of Ch-SeNP Cytotoxicity against Cancer Cells: Insights from Targeted and Untargeted Metabolomics. | Nanomaterials (Basel) | 2023 | 37570523 | PubTator, text mining | PubMed |
| Molecular mechanisms regulating natural menopause in the female ovary: a study based on transcriptomic data. | Front Endocrinol (Lausanne) | 2023 | 37564980 | PubTator, text mining | PubMed |
| Systematic review of mRNA expression in human oocytes: understanding the molecular mechanisms underlying oocyte competence. | J Assist Reprod Genet | 2023 | 37558907 | PubTator, text mining | PubMed |
| Zinc enhances the cell adhesion, migration, and self-renewal potential of human umbilical cord derived mesenchymal stem cells. | World J Stem Cells | 2023 | 37545753 | PubTator, text mining | PubMed |
| A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer. | BMC Cancer | 2023 | 37543645 | PubTator, text mining | PubMed |
| System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma. | PLoS One | 2023 | 37535572 | PubTator, text mining | PubMed |
| Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy. | Cancer Med | 2023 | 37533202 | PubTator, text mining | PubMed |
| Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas. | Front Endocrinol (Lausanne) | 2023 | 37529607 | PubTator, text mining | PubMed |
| Mesenchymal Stromal Cells-Derived Extracellular Vesicles as Potential Treatments for Osteoarthritis. | Pharmaceutics | 2023 | 37514001 | PubTator, text mining | PubMed |
| CDC20 Is Regulated by the Histone Methyltransferase, KMT5A, in Castration-Resistant Prostate Cancer. | Cancers (Basel) | 2023 | 37509260 | PubTator, text mining | PubMed |
| Integration analysis of senescence-related genes to predict prognosis and immunotherapy response in soft-tissue sarcoma: evidence based on machine learning and experiments. | Front Pharmacol | 2023 | 37497116 | PubTator, text mining | PubMed |
| Actionable loss of SLF2 drives B-cell lymphomagenesis and impairs the DNA damage response. | EMBO Mol Med | 2023 | 37485814 | PubTator, text mining | PubMed |
| Comprehensive analysis of the progression mechanisms of CRPC and its inhibitor discovery based on machine learning algorithms. | Front Genet | 2023 | 37476415 | PubTator, text mining | PubMed |
| Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer. | Genome Med | 2023 | 37475004 | PubTator, text mining | PubMed |
| ForestSubtype: a cancer subtype identifying approach based on high-dimensional genomic data and a parallel random forest. | BMC Bioinformatics | 2023 | 37468832 | PubTator, text mining | PubMed |
| CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma. | Cell Death Differ | 2023 | 37468549 | PubTator, text mining | PubMed |
| Important roles of Hif1a in maternal or adult BPA exposure induced pancreatic injuries. | Sci Rep | 2023 | 37460698 | PubTator, text mining | PubMed |
| Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights. | Front Immunol | 2023 | 37457713 | PubTator, text mining | PubMed |
| Pan-cancer evaluation of clinical value of mitotic network activity index (MNAI) and its predictive value for immunotherapy. | Front Oncol | 2023 | 37456231 | PubTator, text mining | PubMed |
| E2F1‑mediated RAB34 upregulation accelerates the proliferation and inhibits the cell cycle arrest and apoptosis of acute myeloid leukemia cells. | Exp Ther Med | 2023 | 37456160 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=12